Doliracetam
![]() | |
| Clinical data | |
|---|---|
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
84901-45-1 |
| PubChem (CID) | 208851 |
| ChemSpider |
180958 |
| UNII |
N70177JQTB |
| ChEMBL |
CHEMBL2106519 |
| Chemical and physical data | |
| Formula | C16H14N2O2 |
| Molar mass | 266.295 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Doliracetam is a nootropic drug (cognition enhancer) from the racetam family used in treatment of epilepsy.[1] According to the patent it has a neuroanabolic action.
See also
References
This article is issued from Wikipedia - version of the 9/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
